All tenders
75N91025C00044
Tumor-Derived Extracellular Vesicles for Ovarian Cancer Diagnosis
National Institutes of Health · United States
This tender closed on Monday, September 14, 2026. Browse open opportunities
Time Left to Bid
Closed
ClosedHealthcare & MedicalFederal
Basic information
- Reference number
- 75N91025C00044
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- Tumor-Derived Extracellular Vesicles for Ovarian Cancer Diagnosis
- Source
- USASpending (Federal)
- Source ID
- usa-75N91025C00044
Details
- Location
- United States
Summary
NIH-funded research project focusing on innovative diagnostic methodology for early-stage ovarian cancer detection using tumor-derived extracellular vesicles. The contract aims to develop a potentially groundbreaking medical diagnostic approach.
Description
TUMOR-DERIVED EXTRACELLULAR VESICLES FOR DIAGNOSIS OF EARLY-STAGE OVARIAN CANCER Awarded to: FYR DIAGNOSTICS INC Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2025/09/15 12:00:00 AM UTC
- Closing date
- 2026/09/14 12:00:00 AM UTC
Estimated value
$355K USD
Classification
Normalized category
Healthcare & Medical